Exhibit 99.1 Contacts: Sherman Miller, President and CEO Max P. Bowman, Vice President and CFO (601) 948-6813 CAL-MAINE FOODS REPORTS RESULTS FOR SECOND QUARTER FISCAL 2025 RIDGELAND, Miss. (January 7, 2025) - Cal-Maine Foods, Inc. (NASDAQ: CALM) ("Cal-Maine Foods" or the "Company"),the largest producer and distributor of freshshell eggs in the UnitedStates, today reported results for the second quarter of fiscal 2025 (thirteen weeks) ended November 30, 2024. Second Quarter Fiscal 2025 Highlights Overview S ...

The Future Investor with Albert Anthony is a new series of curated research articles on the Seeking Alpha platform, focusing on growing a diversified portfolio and unlocking future drivers of performance.Albert Anthony is the pen name of a contributing analyst who has covered over +200 stocks on this platform since 2023, growing to over 1.07K followers. Based on this new article series, he is also working on a new book on Amazon to be called The Future Investor: Growing a Diversified Portfolio (2025 edition ...

CalMaine Foods’ (CALM) shares hit a fresh 52-week high of $99.63 yesterday, before closing the session lower at $96.49.CALM stock has gained 35.3% over the past three months against the industry’s 0.6% dip. It has also outperformed the S&P 500’s rise of 6.1% over the same period. The Basic Materials sector has declined 3.4% in the same time frame.  Image Source: Zacks Investment Research Let us take a look into the factors that are driving CALM stock.CALM Posts Solid 1Q25 Results on Higher Pricing & SalesCa ...

Revitalist Releases Benefits Program Giving Access To All for Ketamine Therapies Changing the Narrative of Mental Health to Risk MitigationNovember 25, 2024 9:59 AM EST | Source: Revitalist Lifestyle & Wellness LtdVancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) (the "Company") announces release of a benefits plan to those seeking ketamine therapies through member subscription. This will help directly ...

Which came first: the chicken or the egg? This age-old question can be posed to investors when choosing between the two premiere stocks for each product, chicken and eggs. One would think the stocks of leading chicken and egg producers would be moving together, but the reality is the opposite. The nation's largest beef and chicken producer, Tyson Foods Inc. NYSE: TSN stock, has recently fallen with a one-month loss of 5.4% and is just starting to get its sea legs as shares are up 9.4% year-to-date (YTD). Th ...

Cal-Maine Foods, Inc. (NASDAQ: CALM ) recently delivered better than expected quarterly results, driven by higher egg prices as well as recent inorganic efforts. The company seemed to react well to recent outbreaks of HPAI thanks to London Stock Market Research is a service offered by an ex-investment banker from the city of London. After around 11 years in the industry, I decided to drop out, and made dollars out of what I learned in business. I appreciate value investments, and I usually buy companies tha ...

Cal-Maine Foods, the largest egg producer and distributor in the U.S., announced a significant increase in its quarterly sales. The rise in egg prices and a reduction in production costs boosted the company's sales by more than 70% compared to the same period last year. For the first quarter of fiscal 2025, Cal-Maine Foods reported sales soaring from $489 million last year to $786 million, surpassing the expected $705 million. The company attributed this growth to higher net average selling prices and incre ...

Index UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended August 31, 2024 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ____________ to ____________ Commission File Number: 001-38695 CAL-MAINE FOODS, INC. (Exact name of registrant as specified in its charter) Delaware 64-0500378 (Sta ...

Exhibit 99.1 Contacts: Sherman Miller, President and CEO Max P. Bowman, Vice President and CFO (601) 948-6813 CAL-MAINE FOODS REPORTS RESULTS FOR FIRST QUARTER FISCAL 2025 RIDGELAND, Miss. (October 1, 2024) - Cal-Maine Foods, Inc. (NASDAQ: CALM) ("Cal-Maine Foods" or the "Company"),the largestproducer anddistributor offresh shelleggs inthe UnitedStates, todayreported results for the first quarter of fiscal 2025 (thirteen weeks) ended August 31, 2024. First Quarter Fiscal 2025 Highlights ● Quarterly net sale ...

Partnership and Collaboration - Revitalist Lifestyle and Wellness Ltd partners with Sama Therapeutics to expand access to mental health care through novel technology, including the release of a proprietary Digital Human Artificial Intelligence Agent [1] - The collaboration aims to enhance mental health assessments globally by integrating advanced AI technology [1][4] Technology and Innovation - The AI Agent, modeled after Revitalist CEO Kathryn Walker, engages patients in conversational dialogue and implements the proprietary Federal Unit Scale (FUS) for mental health screening [2] - The FUS was rigorously validated through an analysis of 11,798 participants, demonstrating strong psychometric properties [2] - Sama's AI Agent platform can create lifelike digital human avatars of healthcare providers, capable of communicating in over 100 languages and capturing audiovisual biomarkers for precise data collection [3] Impact and Vision - The partnership is expected to redefine mental health care accessibility and engagement on a global scale by integrating medically and ethically sound AI in neuropsychiatry [3][4] - The collaboration aims to deliver the highest standard of patient care and clinical research with exceptional efficiency [4] Company Overview - Revitalist Lifestyle and Wellness Ltd is a mental health and wellness company focused on comprehensive care in the ketamine wellness space, operating through physical locations and virtual offices across 35 states [5] - Sama Therapeutics is a leading innovator in AI-powered precision medicine, utilizing its proprietary iMAGiNE™ platform to deliver personalized brain health assessments [6] - Sama integrates generative AI with computational life sciences to redefine "software as a medical device" across various disorders [7] - Sama's mission is to unlock brain health through integrative neurotechnology, transforming psychiatric and neurological medicine [8]